Dyne Therapeutics, Inc. (DYN)

Dyne Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	472.26	435.45	121.63	172.15	200.83	300.85
Short-Term Investments	205.24	206.82	1.47	83.87	175.75	44.46
Cash & Short-Term Investments	677.49	642.27	123.1	256.01	376.57	345.31
Cash Growth	49.38%	421.75%	-51.92%	-32.02%	9.05%	2259.99%
Prepaid Expenses	12.01	17.01	6.28	9.58	5.44	3.77
Restricted Cash	-	-	-	-	0.38	-
Total Current Assets	689.5	659.28	129.38	265.59	382.39	349.09
Property, Plant & Equipment	29.63	30.01	33.39	38.41	40.96	1.95
Other Long-Term Assets	1.94	1.94	2.32	2.32	2.31	2.3
Total Assets	721.07	691.23	165.08	306.33	425.66	353.33
Accounts Payable	7.02	6.56	22.94	5.26	4.03	3.44
Accrued Expenses	21.75	30.85	23.44	18.22	20.74	7.48
Current Portion of Leases	5.11	4.85	4.72	4.61	3.89	-
Other Current Liabilities	-	-	-	0	0.06	0.05
Total Current Liabilities	33.88	42.26	51.1	28.09	28.72	10.97
Long-Term Leases	18.22	19.14	22.7	25.87	28.74	-
Total Liabilities	52.1	61.4	73.79	53.96	57.47	10.97
Common Stock	0.01	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	1,734	1,580	723.8	649.5	596.93	421.57
Retained Earnings	-1,065	-949.93	-632.51	-396.57	-228.47	-79.18
Comprehensive Income & Other	0.24	0.01	-	-0.57	-0.27	-0.03
Total Common Equity	668.97	629.84	91.29	252.36	368.2	342.37
Shareholders' Equity	668.97	629.84	91.29	252.36	368.2	342.37
Total Liabilities & Equity	721.07	691.23	165.08	306.33	425.66	353.33
Total Debt	23.33	23.99	27.42	30.48	32.64	-
Net Cash (Debt)	654.16	618.28	95.69	225.53	343.94	345.31
Net Cash Growth	53.23%	546.16%	-57.57%	-34.43%	-0.40%	2259.99%
Net Cash Per Share	6.45	6.57	1.60	4.34	6.76	23.99
Filing Date Shares Outstanding	113.67	113.12	81.96	56.34	51.6	51.46
Total Common Shares Outstanding	113.63	102.32	61.47	55.63	51.53	45.45
Working Capital	655.62	617.02	78.28	237.51	353.67	338.12
Book Value Per Share	5.89	6.16	1.49	4.54	7.15	7.53
Tangible Book Value	668.97	629.84	91.29	252.36	368.2	342.37
Tangible Book Value Per Share	5.89	6.16	1.49	4.54	7.15	7.53
Machinery	12.66	11.55	9.64	8.67	5.2	2.82
Construction In Progress	0.26	0.62	0.43	0.91	1.46	0.11
Leasehold Improvements	-	-	-	-	-	0.01

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q